Fiji Kava Limited (ASX:FIJ)
Fiji Kava Limited (ASX:FIJ) is a medicinal kava health & wellness company which produces natural ‘noble kava’ products for the complementary and alternative medicine market (which is estimated to exceed USD $210 billion by 2026 globally).
As the first foreign company with approval from the Fijian Government to operate in the kava industry, Fiji Kava has established a global leading sustainable and 100% traceable supply chain of ‘noble kava’ via its world first kava tissue culture laboratory and nucleus farm in Levuka, on the island of Ovalau, Fiji.
Fiji Kava is focussed on expanding the availability of noble kava products to promote sleep, soothe and calm the nerves, support muscle relaxation and relax the mind. Backed by years of independent research, Fiji Kava medical kava products are produced by high-quality GMP and are TGA and FDA compliant.